Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Ascending the learning curve--MSI testing experience of a six-laboratory consortium.

Lindor NM, Smalley R, Barker M, Bigler J, Krumroy LM, Lum-Jones A, Plummer SJ, Selander T, Thomas S, Youash M, Seminara D, Casey G, Bapat B, Thibodeau SN.

Cancer Biomark. 2006;2(1-2):5-9.

PMID:
17192055
2.

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S.

Cancer Res. 1998 Nov 15;58(22):5248-57. Review.

3.

Lynch or not Lynch? Is that always a question?

Colas C, Coulet F, Svrcek M, Collura A, Fléjou JF, Duval A, Hamelin R.

Adv Cancer Res. 2012;113:121-66. doi: 10.1016/B978-0-12-394280-7.00004-X. Review.

PMID:
22429854
4.

Microsatellite instability in the development of DNA mismatch repair deficient tumors.

Woerner SM, Kloor M, von Knebel Doeberitz M, Gebert JF.

Cancer Biomark. 2006;2(1-2):69-86. Review.

PMID:
17192061
5.

[Genomic instability analysis in hereditary cancer syndrome].

Tomita Y, Aozasa K.

Nihon Rinsho. 2000 Jun;58(6):1200-5. Review. Japanese.

PMID:
10879041
6.

Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis.

Buhard O, Suraweera N, Lectard A, Duval A, Hamelin R.

Dis Markers. 2004;20(4-5):251-7. Review.

7.

Lynch syndrome (HNPCC) and microsatellite instability analysis guidelines.

Umar A; International Workshop on Diagnostic Guidelines for Hereditary Non-Polyposis Colorectal Cancer and Microsatellite Instability..

Cancer Biomark. 2006;2(1-2):1-4. Review. No abstract available.

PMID:
17192054
8.

Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer.

Siah SP, Quinn DM, Bennett GD, Casey G, Flower RL, Suthers G, Rudzki Z.

Breast Cancer Res Treat. 2000 Mar;60(2):135-42. Review.

PMID:
10845276
9.
10.

When does MMR loss occur during HNPCC progression?

Shibata D.

Cancer Biomark. 2006;2(1-2):29-35. Review.

PMID:
17192057
11.

Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool.

Kurzawski G, Suchy J, Debniak T, Kładny J, Lubiński J.

Ann Oncol. 2004;15 Suppl 4:iv283-4. Review. No abstract available.

PMID:
15477322
12.

The clinical importance and prognostic implications of microsatellite instability in sporadic cancer.

Lawes DA, SenGupta S, Boulos PB.

Eur J Surg Oncol. 2003 Apr;29(3):201-12. Review.

PMID:
12657227
13.

Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability.

Jass JR, Walsh MD, Barker M, Simms LA, Young J, Leggett BA.

Eur J Cancer. 2002 May;38(7):858-66. Review.

PMID:
11978509
14.

Diagnosis of microsatellite instability-positive colorectal cancer.

Starostik P, Müller-Hermelink HK.

Expert Rev Mol Diagn. 2001 May;1(1):71-80. Review.

PMID:
11901802

Supplemental Content

Support Center